Unknown PHASE4 INTERVENTIONAL NCT00407680

Intensive Medical Treatment for Nephropathy Caused by Type 2 Diabetes With Hypertension

Sponsor: Kitasato University

Conditions Hypertension Type 2 Diabetes Mellitus

Interventions Intensive therapy Valsartan,Fluvastatin

Updated 5 times since 2017 Last updated: Oct 21, 2007 Started: Oct 31, 2006 Completion: Mar 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Hypertension and Type 2 Diabetes Mellitus, this trial is ongoing. The trial is conducted by Kitasato University and has accumulated 5 data snapshots since 2006. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE4
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE4

First recorded

Oct 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Kitasato University
St. Marianna University School of Medicine
Tokai University
Yokohama City University Medical Center

Data source: Kitasato University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• 1-15-1 Kitasato Sagamihara, Japan